HEADER TRANSFERASE/TRANSFERASE INHIBITOR 31-MAY-12 4FF8 TITLE INHIBITOR BOUND STRUCTURE OF THE KINASE DOMAIN OF THE MURINE RECEPTOR TITLE 2 TYROSINE KINASE TYRO3 (SKY) COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE RECEPTOR TYRO3; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ETK2/TYRO3, TK19-2, TYROSINE-PROTEIN KINASE DTK, TYROSINE- COMPND 5 PROTEIN KINASE RSE; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: TYRO3, DTK, RSE; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS RECEPTOR PROTEIN TYROSINE KINASE, PHOSPHOTRANSFERASE, GAS6 (LIGAND), KEYWDS 2 TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.F.OHREN,N.A.POWELL,J.KOHRT,L.A.PERRIN REVDAT 2 28-FEB-24 4FF8 1 REMARK SEQADV REVDAT 1 13-MAR-13 4FF8 0 JRNL AUTH N.A.POWELL,J.K.HOFFMAN,F.L.CISKE,M.D.KAUFMAN,J.T.KOHRT, JRNL AUTH 2 J.QUIN,D.J.SHEEHAN,A.DELANEY,S.M.BAXI,C.CATANA,P.MCCONNELL, JRNL AUTH 3 J.OHREN,L.A.PERRIN,J.J.EDMUNDS JRNL TITL HIGHLY SELECTIVE 2,4-DIAMINOPYRIMIDINE-5-CARBOXAMIDE JRNL TITL 2 INHIBITORS OF SKY KINASE. JRNL REF BIOORG.MED.CHEM.LETT. V. 23 1046 2013 JRNL REFN ISSN 0960-894X JRNL PMID 23312472 JRNL DOI 10.1016/J.BMCL.2012.12.013 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.67 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 95.7 REMARK 3 NUMBER OF REFLECTIONS : 11640 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.279 REMARK 3 R VALUE (WORKING SET) : 0.277 REMARK 3 FREE R VALUE : 0.324 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 607 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.46 REMARK 3 REFLECTION IN BIN (WORKING SET) : 639 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 73.05 REMARK 3 BIN R VALUE (WORKING SET) : 0.2510 REMARK 3 BIN FREE R VALUE SET COUNT : 25 REMARK 3 BIN FREE R VALUE : 0.2910 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1363 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 34 REMARK 3 SOLVENT ATOMS : 3 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 60.81 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.32000 REMARK 3 B22 (A**2) : -1.55000 REMARK 3 B33 (A**2) : 2.73000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.32000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.322 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.275 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.189 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.735 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.888 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.861 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1394 ; 0.010 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 1331 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 1884 ; 1.405 ; 1.951 REMARK 3 BOND ANGLES OTHERS (DEGREES): 3052 ; 0.789 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 164 ; 6.246 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 64 ;34.564 ;23.438 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 240 ;17.208 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 9 ;20.049 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 209 ; 0.077 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1529 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 328 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1319 ; 0.296 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 65 ; 0.105 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 21 ; 0.192 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 2 ; 0.163 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1264 ; 0.446 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1943 ; 0.808 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 863 ; 0.947 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 750 ; 1.398 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 4FF8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-JUL-12. REMARK 100 THE DEPOSITION ID IS D_1000072826. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-JUN-05 REMARK 200 TEMPERATURE (KELVIN) : 200 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : SAGITALLY FOCUSED SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13687 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.240 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.300 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 86.3 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.24 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.32 REMARK 200 COMPLETENESS FOR SHELL (%) : 26.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.23 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 17% PEG 3350, 0.1M MAGNESIUM NITRATE, REMARK 280 0.1 M BIS-TRIS, PH 7.0, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 28.62250 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 484 REMARK 465 LEU A 485 REMARK 465 ASP A 486 REMARK 465 SER A 487 REMARK 465 LEU A 488 REMARK 465 GLY A 489 REMARK 465 ILE A 490 REMARK 465 SER A 491 REMARK 465 ASP A 492 REMARK 465 GLU A 493 REMARK 465 LEU A 494 REMARK 465 LYS A 495 REMARK 465 GLU A 496 REMARK 465 LYS A 497 REMARK 465 LEU A 498 REMARK 465 GLU A 499 REMARK 465 ASP A 500 REMARK 465 VAL A 501 REMARK 465 LEU A 502 REMARK 465 ILE A 503 REMARK 465 PRO A 504 REMARK 465 GLU A 505 REMARK 465 GLN A 506 REMARK 465 GLN A 507 REMARK 465 PHE A 508 REMARK 465 THR A 509 REMARK 465 LEU A 510 REMARK 465 GLY A 511 REMARK 465 ARG A 512 REMARK 465 MET A 513 REMARK 465 LEU A 514 REMARK 465 GLY A 515 REMARK 465 LYS A 516 REMARK 465 GLY A 517 REMARK 465 GLU A 518 REMARK 465 PHE A 519 REMARK 465 GLY A 520 REMARK 465 SER A 521 REMARK 465 VAL A 522 REMARK 465 ARG A 523 REMARK 465 GLU A 524 REMARK 465 ALA A 525 REMARK 465 GLN A 526 REMARK 465 LEU A 527 REMARK 465 LYS A 528 REMARK 465 GLN A 529 REMARK 465 GLU A 530 REMARK 465 ASP A 531 REMARK 465 GLY A 532 REMARK 465 SER A 533 REMARK 465 PHE A 534 REMARK 465 VAL A 535 REMARK 465 LYS A 536 REMARK 465 VAL A 537 REMARK 465 ALA A 538 REMARK 465 VAL A 539 REMARK 465 LYS A 540 REMARK 465 MET A 541 REMARK 465 LEU A 542 REMARK 465 LYS A 543 REMARK 465 ALA A 544 REMARK 465 ASP A 545 REMARK 465 ILE A 546 REMARK 465 ILE A 547 REMARK 465 ALA A 548 REMARK 465 SER A 549 REMARK 465 SER A 550 REMARK 465 ASP A 551 REMARK 465 ILE A 552 REMARK 465 GLU A 553 REMARK 465 GLU A 554 REMARK 465 PHE A 555 REMARK 465 LEU A 556 REMARK 465 ARG A 557 REMARK 465 GLU A 558 REMARK 465 ALA A 559 REMARK 465 ALA A 560 REMARK 465 CYS A 561 REMARK 465 MET A 562 REMARK 465 GLY A 575 REMARK 465 VAL A 576 REMARK 465 SER A 577 REMARK 465 LEU A 578 REMARK 465 ARG A 579 REMARK 465 SER A 580 REMARK 465 ARG A 581 REMARK 465 ALA A 582 REMARK 465 LYS A 583 REMARK 465 GLY A 584 REMARK 465 ARG A 585 REMARK 465 LEU A 586 REMARK 465 PRO A 587 REMARK 465 ILE A 588 REMARK 465 PRO A 589 REMARK 465 MET A 590 REMARK 465 VAL A 591 REMARK 465 GLY A 611 REMARK 465 GLU A 612 REMARK 465 ASN A 613 REMARK 465 PRO A 614 REMARK 465 PHE A 615 REMARK 465 ASN A 616 REMARK 465 LEU A 617 REMARK 465 ASP A 663 REMARK 465 PHE A 664 REMARK 465 GLY A 665 REMARK 465 LEU A 666 REMARK 465 SER A 667 REMARK 465 ARG A 668 REMARK 465 LYS A 669 REMARK 465 ILE A 670 REMARK 465 TYR A 671 REMARK 465 SER A 672 REMARK 465 GLY A 673 REMARK 465 ASP A 674 REMARK 465 TYR A 675 REMARK 465 TYR A 676 REMARK 465 ARG A 677 REMARK 465 GLN A 678 REMARK 465 GLY A 679 REMARK 465 CYS A 680 REMARK 465 ALA A 681 REMARK 465 SER A 682 REMARK 465 LYS A 683 REMARK 465 LEU A 684 REMARK 465 PRO A 685 REMARK 465 GLU A 749 REMARK 465 GLU A 750 REMARK 465 GLY A 781 REMARK 465 HIS A 782 REMARK 465 LEU A 783 REMARK 465 SER A 784 REMARK 465 VAL A 785 REMARK 465 LEU A 786 REMARK 465 SER A 787 REMARK 465 THR A 788 REMARK 465 SER A 789 REMARK 465 GLN A 790 REMARK 465 ASP A 791 REMARK 465 PRO A 792 REMARK 465 LEU A 793 REMARK 465 TYR A 794 REMARK 465 ILE A 795 REMARK 465 ASN A 796 REMARK 465 ILE A 797 REMARK 465 GLU A 798 REMARK 465 ARG A 799 REMARK 465 ALA A 800 REMARK 465 HIS A 801 REMARK 465 HIS A 802 REMARK 465 HIS A 803 REMARK 465 HIS A 804 REMARK 465 HIS A 805 REMARK 465 HIS A 806 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OH TYR A 723 O HOH A 1001 2.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 564 49.96 -96.45 REMARK 500 ARG A 644 -6.39 81.95 REMARK 500 ASP A 645 37.22 -157.74 REMARK 500 PRO A 745 -75.21 -28.32 REMARK 500 ILE A 779 67.28 -62.73 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 14S A 901 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3QUP RELATED DB: PDB REMARK 900 INHIBITOR BOUND STRUCTURE OF THE KINASE DOMAIN OF THE MURINE REMARK 900 RECEPTOR TYROSINE KINASE TYRO3 (SKY) REMARK 900 RELATED ID: 4FEQ RELATED DB: PDB DBREF 4FF8 A 485 800 UNP P55144 TYRO3_MOUSE 485 800 SEQADV 4FF8 MET A 484 UNP P55144 INITIATING METHIONINE SEQADV 4FF8 HIS A 801 UNP P55144 EXPRESSION TAG SEQADV 4FF8 HIS A 802 UNP P55144 EXPRESSION TAG SEQADV 4FF8 HIS A 803 UNP P55144 EXPRESSION TAG SEQADV 4FF8 HIS A 804 UNP P55144 EXPRESSION TAG SEQADV 4FF8 HIS A 805 UNP P55144 EXPRESSION TAG SEQADV 4FF8 HIS A 806 UNP P55144 EXPRESSION TAG SEQRES 1 A 323 MET LEU ASP SER LEU GLY ILE SER ASP GLU LEU LYS GLU SEQRES 2 A 323 LYS LEU GLU ASP VAL LEU ILE PRO GLU GLN GLN PHE THR SEQRES 3 A 323 LEU GLY ARG MET LEU GLY LYS GLY GLU PHE GLY SER VAL SEQRES 4 A 323 ARG GLU ALA GLN LEU LYS GLN GLU ASP GLY SER PHE VAL SEQRES 5 A 323 LYS VAL ALA VAL LYS MET LEU LYS ALA ASP ILE ILE ALA SEQRES 6 A 323 SER SER ASP ILE GLU GLU PHE LEU ARG GLU ALA ALA CYS SEQRES 7 A 323 MET LYS GLU PHE ASP HIS PRO HIS VAL ALA LYS LEU VAL SEQRES 8 A 323 GLY VAL SER LEU ARG SER ARG ALA LYS GLY ARG LEU PRO SEQRES 9 A 323 ILE PRO MET VAL ILE LEU PRO PHE MET LYS HIS GLY ASP SEQRES 10 A 323 LEU HIS ALA PHE LEU LEU ALA SER ARG ILE GLY GLU ASN SEQRES 11 A 323 PRO PHE ASN LEU PRO LEU GLN THR LEU VAL ARG PHE MET SEQRES 12 A 323 VAL ASP ILE ALA CYS GLY MET GLU TYR LEU SER SER ARG SEQRES 13 A 323 ASN PHE ILE HIS ARG ASP LEU ALA ALA ARG ASN CYS MET SEQRES 14 A 323 LEU ALA GLU ASP MET THR VAL CYS VAL ALA ASP PHE GLY SEQRES 15 A 323 LEU SER ARG LYS ILE TYR SER GLY ASP TYR TYR ARG GLN SEQRES 16 A 323 GLY CYS ALA SER LYS LEU PRO VAL LYS TRP LEU ALA LEU SEQRES 17 A 323 GLU SER LEU ALA ASP ASN LEU TYR THR VAL HIS SER ASP SEQRES 18 A 323 VAL TRP ALA PHE GLY VAL THR MET TRP GLU ILE MET THR SEQRES 19 A 323 ARG GLY GLN THR PRO TYR ALA GLY ILE GLU ASN ALA GLU SEQRES 20 A 323 ILE TYR ASN TYR LEU ILE GLY GLY ASN ARG LEU LYS GLN SEQRES 21 A 323 PRO PRO GLU CYS MET GLU GLU VAL TYR ASP LEU MET TYR SEQRES 22 A 323 GLN CYS TRP SER ALA ASP PRO LYS GLN ARG PRO SER PHE SEQRES 23 A 323 THR CYS LEU ARG MET GLU LEU GLU ASN ILE LEU GLY HIS SEQRES 24 A 323 LEU SER VAL LEU SER THR SER GLN ASP PRO LEU TYR ILE SEQRES 25 A 323 ASN ILE GLU ARG ALA HIS HIS HIS HIS HIS HIS HET 14S A 901 34 HETNAM 14S 4-(CYCLOPENTYLAMINO)-2-[(2-METHOXYBENZYL)AMINO]-N-[3- HETNAM 2 14S (2-OXOPYRROLIDIN-1-YL)PROPYL]PYRIMIDINE-5-CARBOXAMIDE FORMUL 2 14S C25 H34 N6 O3 FORMUL 3 HOH *3(H2 O) HELIX 1 1 ASP A 600 ILE A 610 1 11 HELIX 2 2 LEU A 619 ARG A 639 1 21 HELIX 3 3 ALA A 647 ARG A 649 5 3 HELIX 4 4 ALA A 690 ASN A 697 1 8 HELIX 5 5 THR A 700 THR A 717 1 18 HELIX 6 6 GLU A 727 ALA A 729 5 3 HELIX 7 7 GLU A 730 GLY A 737 1 8 HELIX 8 8 TYR A 752 CYS A 758 1 7 HELIX 9 9 ASP A 762 ARG A 766 5 5 HELIX 10 10 SER A 768 ILE A 779 1 12 SHEET 1 A 2 CYS A 651 LEU A 653 0 SHEET 2 A 2 VAL A 659 VAL A 661 -1 O CYS A 660 N MET A 652 SITE 1 AC1 10 ALA A 571 LEU A 593 PRO A 594 PHE A 595 SITE 2 AC1 10 MET A 596 LYS A 597 GLY A 599 ASP A 600 SITE 3 AC1 10 MET A 652 ALA A 662 CRYST1 48.522 57.245 60.076 90.00 100.85 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020609 0.000000 0.003950 0.00000 SCALE2 0.000000 0.017469 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016949 0.00000